RHI:NYSERobert Half Inc. Analysis
Data as of 2026-08-30 - not real-time
$45.31
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
At $45.31, Robert Half Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. The last 30 days have gained 8.4%. Momentum indicators put RSI at 65.7 (approaching overbought) with MACD reading bearish. Watch $37.34 as support and $46.70 as the nearer resistance level.
Multiples put this in overvalued territory: 39.1 times earnings against the sector's 29.4. Sell-side targets cluster 22.8% below the current quote. Revenue is contracting at 2.4% on a 2.2% profit margin. The 5.21% dividend yield looks stretched against payout coverage.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 60.5%, a beta of 0.30 and a maximum drawdown of 41.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons diverge: hold near-term but sell on a long view, at 4/10 conviction over the longer horizon.
Multiples put this in overvalued territory: 39.1 times earnings against the sector's 29.4. Sell-side targets cluster 22.8% below the current quote. Revenue is contracting at 2.4% on a 2.2% profit margin. The 5.21% dividend yield looks stretched against payout coverage.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 60.5%, a beta of 0.30 and a maximum drawdown of 41.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons diverge: hold near-term but sell on a long view, at 4/10 conviction over the longer horizon.
Top Market Events
Shares of specialized talent solutions company Robert Half NYSE:RHI fell 6.Staffing firm Robert Half beat on both earnings and revenue in Q2 as white-collar hiring stabilizes after two years of...Specialized talent solutions company Robert Half NYSE:RHI reported revenue ahead of Wall Street’s expectations in Q2...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 29.90
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 39.1 versus sector average of 29.4
- Dividend yield of 5.21% looks stretched against payout coverage
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- P/E of 39.1 versus sector average of 29.4
- Dividend yield of 5.21% looks stretched against payout coverage
- Analyst targets imply -22.8% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth-2.40%
Profit Margin2.17%
P/E Ratio39.1
ROE9.11%
ROA0.23%
Debt/Equity19.94
P/B Ratio3.8
Op. Cash Flow$256.3M
Free Cash Flow$113.6M
Industry P/E29.4
Technical Analysis
TrendBullish
RSI65.7
Support$37.34
Resistance$46.70
MA 20$43.02
MA 50$38.42
MA 200$29.90
MACDBearish
VolumeIncreasing
Fear & Greed Index95.66
Valuation
Fair Value$15.06
Target Price$35.00
Upside/Downside-22.75%
GradeOvervalued
TypeBlend
Dividend Yield5.21%
Risk Assessment
Beta0.30
Volatility60.54%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.